References
- Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 6(2), 91–99 (2006).
- Zheng R, Xie S, Lu X et al. A systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in China. Biomed. Res. Int. 2018, 5712920 (2018).
- Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLOS Negl. Trop. Dis. 6(12), e1929 (2012).
- Haji-Abdolbagi M, Rasooli-Nejad M, Jafari S, Hasibi M, Soudbakhsh A. Clinical and laboratory findings in neurobrucellosis: review of 31 cases. Arch. Iran Med. 11(1), 21–25 (2008).
- Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int. J. Infect Dis. 13(6), e339–e343 (2009).
- Guven T, Ugurlu K, Ergonul O et al. Neurobrucellosis: clinical and diagnostic features. Clin. Infect Dis. 56(10), 1407–1412 (2013).
- Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin. Microbiol. Rev. 33(1), e00073–19 (2019).
- Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu. Rev. Pathol. 14, 319–338 (2019).
- Chiu CY, Miller SA. Clinical metagenomics. Nat. Rev. Genet. 20(6), 341–355 (2019).
- Xing XW, Zhang JT, Ma YB et al. Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: a large, prospective case series of 213 patients. Front. Cell. Infect. Microbiol. 10, 88 (2020).
- Mongkolrattanothai K, Naccache SN, Bender JM et al. Neurobrucellosis: unexpected answer from metagenomic next-generation sequencing. J. Pediatric. Infect Dis. Soc. 6(4), 393–398 (2017).
- Fan S, Ren H, Wei Y et al. Next-generation sequencing of the cerebrospinal fluid in the diagnosis of neurobrucellosis. Int. J. Infect. Dis. 67, 20–24 (2018).
- Zhao W, Lin F, Qiao X et al. Retrospective analysis of metagenomic next-generation sequencing in the diagnosis of central nervous system in infectious diseases. Chin. J. Neural. 53(12), 1016–1020 (2020).
- Jin K, Wang X, Guan H et al. Application of second generation sequencing in Brucella infection of central nervous system. Chin. J. Clin. Infect Dis. 13(3), 195–198 (2020).
- Cao J, Cai Q, Su W et al. Case report: metagenomic next-generation sequencing confirmed a case of central nervous system infection with Brucella melitensis in non-endemic areas. Front. Med. (Lausanne) 8, 723197 (2021).
- Geng L, Feng Y, Li D et al. Meningoencephalitis, coronary artery and keratitis as an onset of brucellosis: a case report. BMC Infect. Dis. 20(1), 654 (2020).
- Ye H, Gao R, Zhang J et al. Comparative study of metagenomics next generation sequencing of cerebrospinal fluid in the diagnosis test of the pathogen of neurobrucellosis. Chin. J. Neurol. 54(11), 1128–1133 (2021).
- Hayoun MA, Muco E, Shorman M. Brucellosis. In: StatPearls. StatPearls Publishing; Treasure Island (FL) (April 29, 2023).
- Glowacka P, Zakowska D, Naylor K, Niemcewicz M, Bielawska-Drozd A. Brucella – virulence factors, pathogenesis and treatment. Pol. J. Microbiol. 67(2), 151–161 (2018).
- Ceran N, Turkoglu R, Erdem I et al. Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region. Braz. J. Infect Dis. 15(1), 52–59 (2011).
- Handattu K, Bhaskaranand N, Kini SB. Neurobrucellosis mimicking neurotuberculosis. Indian J. Pediatr. 85(7), 574 (2018).
- Avijgan M, Rostamnezhad M, Jahanbani-Ardakani H. Clinical and serological approach to patients with brucellosis: a common diagnostic dilemma and a worldwide perspective. Microb. Pathog. 129, 125–130 (2019).
- Ruiz Castaneda M. Laboratory diagnosis of brucellosis in man. Bull. World Health Organ. 24(1), 73–84 (1961).
- Diaz R, Casanova A, Ariza J, Moriyon I. The rose bengal test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLOS Negl. Trop. Dis. 5(4), e950 (2011).
- Shemesh AA, Yagupsky P. Limitations of the standard agglutination test for detecting patients with Brucella melitensis bacteremia. Vector Borne Zoonotic Dis. 11(12), 1599–1601 (2011).
- Bustin SA, Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin. Sci. (Lond.) 109(4), 365–379 (2005).
- Li N, Cai Q, Miao Q, Song Z, Fang Y, Hu B. High-throughput metagenomics for identification of pathogens in the clinical settings. Small Methods 5(1), 2000792 (2021).
- Wilson MR, Sample HA, Zorn KC et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N. Engl. J. Med. 380(24), 2327–2340 (2019).
- Whatmore AM. Ancient-pathogen genomics: coming of age? mBio 5(5), e01676–14 (2014).
- Bouferraa Y, Bou Zerdan M, Hamouche R, Azar E, Afif C, Jabbour R. Neurobrucellosis: brief review. Neurologist 26(6), 248–252 (2021).
- Zhao S, Cheng Y, Liao Y, Zhang Z, Yin X, Shi S. Treatment efficacy and risk factors of neurobrucellosis. Med. Sci. Monit. 22, 1005–1012 (2016).